As part of JCI’s ongoing review series on pancreatic cancer Vasiliki Pantazopoulou et al. discuss nuances of experimental models and the use of patient-derived systems for improving outcomes.
1Salk Institute for Biological Studies, San Diego, California, USA.
2Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden.
3Department of Surgery, Division of Surgical Oncology, Moores Cancer Center, UCSD, San Diego, California, USA.